The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer

Comment

Cary Siegel. J Urol. 2003 Jul.

. 2003 Jul;170(1):321.

No abstract available

Comment on

The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer.
Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J. Safaei A, et al. Clin Nephrol. 2002 Jan;57(1):56-62. doi: 10.5414/cnp57056. Clin Nephrol. 2002. PMID: 11837802

Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer.
Shen YY, Shiau YC, Wang JJ, Ho ST, Kao CH. Shen YY, et al. Anticancer Res. 2002 Mar-Apr;22(2B):1257-64. Anticancer Res. 2002. PMID: 12168935
Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma.
Roe RH, Finger PT, Kurli M, Tena LB, Iacob CE. Roe RH, et al. Ophthalmology. 2006 Oct;113(10):1854-8. doi: 10.1016/j.ophtha.2006.04.029. Epub 2006 Jul 24. Ophthalmology. 2006. PMID: 16860867
The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
Deonarine P, Han S, Poon FW, de Wet C. Deonarine P, et al. Scott Med J. 2013 Aug;58(3):154-62. doi: 10.1177/0036933013496958. Scott Med J. 2013. PMID: 23960054
[Positron emission tomography (PET): application in urogenital system oncologic diseases].
Lomeña F, Simó M, Setoain X, Pérez G. Lomeña F, et al. Arch Esp Urol. 2001 Jul-Aug;54(6):649-60. Arch Esp Urol. 2001. PMID: 11512406 Review. Spanish.
Positron emission tomography in urologic oncology.
Shvarts O, Han KR, Seltzer M, Pantuck AJ, Belldegrun AS. Shvarts O, et al. Cancer Control. 2002 Jul-Aug;9(4):335-42. doi: 10.1177/107327480200900408. Cancer Control. 2002. PMID: 12228759 Review.